Document is current
Any future updates will be listed below
-
Authors
Khan, Sara https://orcid.org/0000-0001-5411-3383
Shridharmurthy, Divya
Lapane, Kate L.
Dube, Catherine
Kay, Jonathan
Yi, Esther
Liu, Shao-Hsien
-
Funding
Funding for this research was provided by:
Spondyloarthritis Research and Treatment Network
SAA/Jane Bruckel Early Career Investigator in SpA Award
Novartis Pharmaceuticals Corporation
UMass Memorial Foundation from Timothy S. and Elaine L. Peterson
- License Information
-
More Information
Article History
Received: 12 August 2021
Revised: 30 November 2021
Accepted: 1 December 2021
First Online: 6 January 2022
Declarations
:
: All procedures in this study were conducted in accordance with the UMass Medical School Institutional Review Board (H00016873). The data were used for secondary analyses. The University of Massachusetts Institutional Review Board considered this study exempt and the informed consent was waived (H00019354).
: Not applicable.
: Esther Yi, PharmD, is an employee of Novartis Pharmaceuticals Corporation. Authors Sara Khan, Divya Shridharmurthy, Kate L. Lapane, PhD, Catherine Dube, EdD, Jonathan Kay, MD, and Shao-Hsien Liu, MPH, PhD, have no competing interests directly related to this study.
